54 related articles for article (PubMed ID: 10230438)
1. [1H-MR spectroscopy in anorexia nervosa: the characteristic differences between patients and healthy subjects].
Hentschel J; Möckel R; Schlemmer HP; Markus A; Göpel C; Gückel F; Köpke J; Georgi M; Schmidt MH
Rofo; 1999 Mar; 170(3):284-9. PubMed ID: 10230438
[TBL] [Abstract][Full Text] [Related]
2. [1H-MR spectroscopy in anorexia nervosa: reversible cerebral metabolic changes].
Möckel R; Schlemmer HP; Gückel F; Göpel C; Becker G; Köpke J; Hentschel F; Schmidt M; Georgi M
Rofo; 1999 Apr; 170(4):371-7. PubMed ID: 10341796
[TBL] [Abstract][Full Text] [Related]
3. [31P-MR spectroscopy of the brain in patients with anorexia nervosa: characteristic differences in the spectra between patients and healthy control subjects].
Rzanny R; Freesmeyer D; Reichenbach JR; Mentzel HJ; Pfleiderer SO; Klemm S; Gerhard UJ; Blanz B; Kaiser WA
Rofo; 2003 Jan; 175(1):75-82. PubMed ID: 12525985
[TBL] [Abstract][Full Text] [Related]
4. [Brain metabolism alterations in patients with anorexia nervosa observed in 1H-MRS].
Grzelak P; Gajewicz W; Wyszogrodzka-Kucharska A; Rotkiewicz A; Stefańczyk L; Góraj B; Rabe-Jabłońska J
Psychiatr Pol; 2005; 39(4):761-71. PubMed ID: 16237980
[TBL] [Abstract][Full Text] [Related]
5. Adolescent anorexia nervosa: cross-sectional and follow-up frontal gray matter disturbances detected with proton magnetic resonance spectroscopy.
Castro-Fornieles J; Bargalló N; Lázaro L; Andrés S; Falcon C; Plana MT; Junqué C
J Psychiatr Res; 2007 Dec; 41(11):952-8. PubMed ID: 17112540
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
[TBL] [Abstract][Full Text] [Related]
7. Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury.
Schweinsburg BC; Taylor MJ; Alhassoon OM; Videen JS; Brown GG; Patterson TL; Berger F; Grant I
Alcohol Clin Exp Res; 2001 Jun; 25(6):924-34. PubMed ID: 11410730
[TBL] [Abstract][Full Text] [Related]
8. Thalamic involvement in neurofibromatosis type 1: evaluation with proton magnetic resonance spectroscopic imaging.
Wang PY; Kaufmann WE; Koth CW; Denckla MB; Barker PB
Ann Neurol; 2000 Apr; 47(4):477-84. PubMed ID: 10762159
[TBL] [Abstract][Full Text] [Related]
9. [1H-MR spectroscopic imaging in patients with clinically diagnosed Alzheimer's disease].
Block W; Träber F; Kuhl CK; Fric M; Keller E; Lamerichs R; Rink H; Möller HJ; Schild HH
Rofo; 1995 Sep; 163(3):230-7. PubMed ID: 7548870
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
Blasi G; Bertolino A; Brudaglio F; Sciota D; Altamura M; Antonucci N; Scarabino T; Weinberger DR; Nardini M
Psychiatry Res; 2004 Jul; 131(2):95-105. PubMed ID: 15313516
[TBL] [Abstract][Full Text] [Related]
11. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
12. A proton magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in acute mania.
Frey BN; Folgierini M; Nicoletti M; Machado-Vieira R; Stanley JA; Soares JC; Kapczinski F
Hum Psychopharmacol; 2005 Mar; 20(2):133-9. PubMed ID: 15648094
[TBL] [Abstract][Full Text] [Related]
13. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
[TBL] [Abstract][Full Text] [Related]
14. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder.
Iranzo A; Santamaria J; Pujol J; Moreno A; Deus J; Tolosa E
Sleep; 2002 Dec; 25(8):867-70. PubMed ID: 12489892
[TBL] [Abstract][Full Text] [Related]
15. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
Dubey P; Fatemi A; Barker PB; Degaonkar M; Troeger M; Zackowski K; Bastian A; Smith SA; Pomper MG; Moser HW; Raymond GV
Neurology; 2005 Jan; 64(2):304-10. PubMed ID: 15668429
[TBL] [Abstract][Full Text] [Related]
16. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
Garcia M; Huppertz HJ; Ziyeh S; Buechert M; Schumacher M; Mader I
Epilepsia; 2009 Mar; 50(3):486-92. PubMed ID: 19183221
[TBL] [Abstract][Full Text] [Related]
17. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
18. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis.
Yildiz-Yesiloglu A; Ankerst DP
Psychiatry Res; 2006 Jun; 147(1):1-25. PubMed ID: 16806850
[TBL] [Abstract][Full Text] [Related]
19. Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder.
Scherk H; Backens M; Schneider-Axmann T; Kemmer C; Usher J; Reith W; Falkai P; Gruber O
Acta Psychiatr Scand; 2008 Apr; 117(4):283-8. PubMed ID: 18205896
[TBL] [Abstract][Full Text] [Related]
20. [Thalamic spectroscopy using magnetic resonance in autism].
Perich-Alsina J; Aduna de Paz M; Valls A; Muñoz-Yunta JA
Rev Neurol; 2002 Feb; 34 Suppl 1():S68-71. PubMed ID: 12447793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
